ANNX
Annexon, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.87
+0.62%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.26
- Revenue estimate
- $3.5M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.28
- EPS estimate
- -$0.24
- Revenue actual
- —
- Revenue estimate
- $6.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +6.0%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $14
- PT range
- $3.00 – $25
- Analysts
- 3
2 Buy1 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026